Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial

Claus‐C. Glüer, Fernando Marín, J. D. Ringe, +19

Journal of Bone and Mineral Research

Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis

J Štěpán, David B. Burr, Imre Pávó, +9

Bone

Low BoneBone HealthMedicineGynecologyBone Metabolism +7

High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosis

Christian Graeff, Fernando Marín, Helmut Petto, +5

Bone

Strength EstimatesBone ImagingHigh ResolutionBiomechanicsOsteoarthritis +8

Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes

Baptist Gallwitz, Michael Böhmer, Thomas Segiet, +7

Diabetes Care

Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate

Harald Dobnig, J Štěpán, David B. Burr, +6

Journal of Bone and Mineral Research

Bone DiseaseBone Turnover MarkersBone HealthMedicineMicrodamage Accumulation +9

Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis

J Štěpán, David B. Burr, J. Li, +7

Osteoporosis International

Alendronate-pretreated WomenOsteoarthritisMetabolic Bone DiseaseMedicineOsteoporosis +1

Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common Comparator

Helmut Petto, Zbigniew Kadziola, Alan Brnabic, +2

Value in Health

Common ComparatorSelection BiasMatching TechniqueAlternative Weighting ApproachesBiostatistics +3

Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture

Per Aspenberg, Jorge Malouf, Umberto Tarantino, +11

Journal of Bone and Joint Surgery

Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)

Bente Langdahl, Östen Ljunggren, Claude-Laurent Benhamou, +9

Calcified Tissue International

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

P. Farahmand, Fernando Marín, Federico Hawkins, +18

Osteoporosis International